2017-06-302026-03-272017-06-302012María Teresa Cordero Ortíz0891-584910.1016/j.freeradbiomed.2012.06.040https://doi.org/10.1016/j.freeradbiomed.2012.06.040https://repositorio.inprf.gob.mx/handle/123456789/6790engacceso cerradoRETRACTED: S-allyl cysteine protects against 6-hydroxydopamine-induced neurotoxicity in the rat striatum: involvement of Nrf2 transcription factor activation and modulation of signaling kinase cascadesarticle1873-45965Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz1024-1040Estados Unidos53SAC6-OHDANrf2NeuroprotectionOxidative stressParkinson’s diseaseS-alil cisteína (SAC)6-OHDANrf2NeuroprotecciónEstrés oxidativoEnfermedad de ParkinsonAnimalsCysteine-Analogs & derivativesCysteine-Analogs & derivativesCysteine-Chemical synthesisCysteine-ChemistryCysteine-PharmacologyCysteine-PharmacologyJNK Mitogen-Activated Protein Kinases-Antagonists & inhibitorsJNK Mitogen-Activated Protein Kinases-MetabolismMAP Kinase Signaling System-Drug effectsMaleMitogen-Activated Protein Kinase 1-MetabolismMitogen-Activated Protein Kinase 3-MetabolismNF-E2-Related Factor 2-GeneticsNF-E2-Related Factor 2-MetabolismNeostriatum-Drug effectsNeostriatum-EnzymologyNeostriatum-MetabolismOxidopamine-ToxicityPC12 CellsProto-Oncogene Proteins c-akt-MetabolismRatsRats, WistarSignal Transduction-Drug effectsTumor Cells, Cultured